SCHEMBL24791052

SCHEMBL24791052

CC(=O)OCOC(=O)Nc1ncnn2c([C@H]3CC[C@@H](COC(=O)Cc4ccccc4)O3)ccc12

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.36
▸ LMNA P02545 2/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ KLK6 Q92876 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24791051 0.89 MGLL (0.35) MGLLLMNAKMT2A
SCHEMBL24916936 0.85 MGLL (0.33) MGLL
SCHEMBL24917284 0.84 MGLL (0.32) MGLL
SCHEMBL26200336 0.82 PDE2A (0.31) —
SCHEMBL26200344 0.78 TSHR (0.34) LMNA
SCHEMBL25919377 0.76 MGLL (0.35) MGLLKMT2A
SCHEMBL24982214 0.76 PDE2A (0.31) —
SCHEMBL25914469 0.75 CHRM1 (0.31) —
SCHEMBL25914471 0.75 KDR (0.31) —
SCHEMBL24606323 0.74 TSHR (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022265964-A1 ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS VenatoRx Pharmaceuticals, Inc. (US) 2022-12-22 — — WO disclosed
Send feedback